WCN26-8962 Effect on BP and Renal Outcomes with Cilnidipine-based therapy in Hypertensive CKD Patients with or without T2DM: A Two-Year Real-World Analysis

Read full text Summarise with VIRAT
Authors: Deepak Dewan, Aafreen Naik, Kapil Dev Mehta
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Hypertension and chronic kidney disease (CKD) form a bidirectional clinical challenge, each accelerating the progression of the other, contributing to high cardiovascular risk. The coexistence of diabetes further amplifies this risk, making effective blood pressure (BP) control and organ-protection a cornerstone of management. In India, where hypertension frequently presents early and diabetic kidney disease is highly prevalent, selection of the right antihypertensive therapy is crucial. Amongst CCBs, Cilnidipine, a 4th generation L/N-type CCB, has exhibited sympatholytic and reno-protective actions in documented studies.

Fields of Study & Subjects

Blood Pressure and Hypertension Studies Chronic Kidney Disease and Diabetes Acute Kidney Injury Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105050–105050
Publication date
25 March 2026
Language
EN